Skip to content
Blackberry Empire – Lifestyle
Author:
Prime Medicine, Inc.
Prime Medicine Receives U.S. FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for PM359 for the Treatment of Chronic Granulomatous Disease (CGD)
June 22, 2026
Prime Medicine Announces New Zealand Clearance of Clinical Trial Application for PM577a in H1069Q-mutated Wilson Disease
June 18, 2026
Prime Medicine to Present at Goldman Sachs 47th Annual Global Healthcare Conference
June 3, 2026
Prime Medicine to Present at Jefferies Global Healthcare Conference
May 28, 2026
Prime Medicine Reports First Quarter 2026 Financial Results and Provides Business Updates
May 7, 2026
Prime Medicine Appoints Svetlana Makhni as Chief Financial Officer
April 16, 2026